BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17308987)

  • 1. Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
    de Vries F; Souverein PC; Cooper C; Leufkens HG; van Staa TP
    Calcif Tissue Int; 2007 Feb; 80(2):69-75. PubMed ID: 17308987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of alpha-blockers and the risk of hip/femur fractures.
    Souverein PC; Van Staa TP; Egberts AC; De la Rosette JJ; Cooper C; Leufkens HG
    J Intern Med; 2003 Dec; 254(6):548-54. PubMed ID: 14641795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hip/femur fracture after stroke: a population-based case-control study.
    Pouwels S; Lalmohamed A; Leufkens B; de Boer A; Cooper C; van Staa T; de Vries F
    Stroke; 2009 Oct; 40(10):3281-5. PubMed ID: 19661475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.
    Pouwels S; Lalmohamed A; Souverein P; Cooper C; Veldt BJ; Leufkens HG; de Boer A; van Staa T; de Vries F
    Osteoporos Int; 2011 Mar; 22(3):903-10. PubMed ID: 20585937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study.
    Arbouw ME; Movig KL; van Staa TP; Egberts AC; Souverein PC; de Vries F
    Osteoporos Int; 2011 Jul; 22(7):2197-204. PubMed ID: 20967420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of beta-blockers and risk of fractures.
    Schlienger RG; Kraenzlin ME; Jick SS; Meier CR
    JAMA; 2004 Sep; 292(11):1326-32. PubMed ID: 15367554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of anti-depressants and the risk of fracture of the hip or femur.
    van den Brand MW; Pouwels S; Samson MM; van Staa TP; Thio B; Cooper C; Leufkens HG; Egberts AC; Verhaar HJ; de Vries F
    Osteoporos Int; 2009 Oct; 20(10):1705-13. PubMed ID: 19238308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study.
    de Vries F; Pouwels S; Bracke M; Leufkens HG; Cooper C; Lammers JW; van Staa TP
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):612-9. PubMed ID: 16998945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
    Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
    Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of hip/femur fractures in patients using antipsychotics.
    Hugenholtz GW; Heerdink ER; van Staa TP; Nolen WA; Egberts AC
    Bone; 2005 Dec; 37(6):864-70. PubMed ID: 16111927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of modified release alpha-blocker exposure in elderly patients with fractures.
    Hall GC; McMahon AD
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):901-7. PubMed ID: 17443863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of bone fracture after long-term risperidone exposure is not increased compared to other atypical antipsychotics: A retrospective cohort study.
    Shen SP; Liu Y; Qiu H; Tsai KY; Wu HC; Liang WM; Shu M; Chou FH
    PLoS One; 2019; 14(9):e0221948. PubMed ID: 31487309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study.
    Brauchli YB; Jick SS; Curtin F; Meier CR
    Br J Dermatol; 2008 Jun; 158(6):1299-307. PubMed ID: 18410416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levothyroxine treatment and occurrence of fracture of the hip.
    Sheppard MC; Holder R; Franklyn JA
    Arch Intern Med; 2002 Feb; 162(3):338-43. PubMed ID: 11822927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
    de Vries F; Pouwels S; Lammers JW; Leufkens HG; Bracke M; Cooper C; van Staa TP
    J Intern Med; 2007 Feb; 261(2):170-7. PubMed ID: 17241182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.
    Pouwels S; van Staa TP; Egberts AC; Leufkens HG; Cooper C; de Vries F
    Osteoporos Int; 2009 Sep; 20(9):1499-506. PubMed ID: 19156348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of organic nitrates and the risk of hip fracture: a population-based case-control study.
    Pouwels S; Lalmohamed A; van Staa T; Cooper C; Souverein P; Leufkens HG; Rejnmark L; de Boer A; Vestergaard P; de Vries F
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1924-31. PubMed ID: 20130070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects.
    Toulis KA; Hemming K; Stergianos S; Nirantharakumar K; Bilezikian JP
    Osteoporos Int; 2014 Jan; 25(1):121-9. PubMed ID: 24114396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study.
    Pasco JA; Henry MJ; Sanders KM; Kotowicz MA; Seeman E; Nicholson GC;
    J Bone Miner Res; 2004 Jan; 19(1):19-24. PubMed ID: 14753732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of fracture in incident multiple sclerosis patients: the Danish National Health Registers.
    Bazelier MT; Bentzen J; Vestergaard P; Stenager E; Leufkens HG; van Staa TP; de Vries F
    Mult Scler; 2012 Nov; 18(11):1609-16. PubMed ID: 22472998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.